申请人:Huck Bayard R.
公开号:US20130252942A1
公开(公告)日:2013-09-26
The invention provides novel quinazoline carboxamide azetidine compounds according to Formula (I) and use for the treatment of hyperproliferative diseases, such as cancer.
该发明提供了一种新型的
喹唑啉羧酰胺氮
杂环化合物,其
化学式为(I),并可用于治疗高增殖性疾病,例如癌症。